| 000 | 01834nam a22002657a 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20260107160039.0 | ||
| 006 | a||||dr|||| 00| 0 | ||
| 007 | ta | ||
| 008 | 250912t2024 ||||||||r|||| 00| 0 eng d | ||
| 020 | _a978-621-416-145-4 | ||
| 040 | _cUM Bansalan College LIC | ||
| 082 |
_aBFil. 657.044 _bV238i |
||
| 100 |
_aValix, Conrado T., author _9579 |
||
| 245 |
_aIntermediate accounting / _cby Conrado T. Valix and Christian Aris M. Valix |
||
| 250 | _a2024 Revised edition | ||
| 260 |
_aSampaloc, Manila, Philippines : _bGIC Enterprises & Co., Inc., _cc2024 |
||
| 300 |
_a726 pages ; _c22 centimeters |
||
| 336 | _ardacontent | ||
| 440 | _vVolume 3 | ||
| 505 | _aContents: 1. Financial Statements.-- 2. Statement of Financial Position.-- 3. Notes to Financial Statements.-- 4. Related Parties; Events after Reporting Period.-- 5. Statement of Financial Performance.-- 6. Statement of Changes in Equity.--7. Noncurrent Asset Held for Sale.-- 8. Discontinued Operation.-- 9. Accounting Changes (Prior period errors).-- 10. Interim Financial Reporting.-- 11. Operating Segment.-- 12. Derivatives (Interest rate swap).-- 13. Derivatives (Forward, futures and option).-- 14. Cash Surrender Value.-- 15. Biological Asset.-- 16. Cash and Accrual Basis.-- 17. Single Entry.-- 18. Error Correction.-- 19. Statement of Cash Flows.-- 20. Book Value per Share.-- 21. Basic Earnings per Share.-- 22. Diluted Earnings per Share.-- 23. Diluted Earnings per Share (Multiple potential ordinary shares).-- 24. Hyperinflation.-- 25. Current Cost Accounting.-- 26. SMEs - Definition.-- 27. SMEs - Financial Statements.-- 28. SMEs - Assets.-- 29. SMEs - Assets.-- 30. SMEs - Liabilities.-- 31. SMEs - Equity.-- 32. Small Entities. | ||
| 650 | 0 |
_aAccounting _94204 |
|
| 700 |
_aValix, Christian Aris M. _9315 |
||
| 942 |
_2ddc _cBFI |
||
| 999 |
_c11068 _d11068 |
||